BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15492142)

  • 1. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
    Jeng KS; Sheen IS; Tsai YC
    Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
    Jeng KS; Sheen IS; Tsai YC
    Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
    Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
    Ijichi M; Takayama T; Matsumura M; Shiratori Y; Omata M; Makuuchi M
    Hepatology; 2002 Apr; 35(4):853-60. PubMed ID: 11915031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of AFP mRNA-expressing cells in the peripheral blood for prediction of HCC recurrence after living donor liver transplantation.
    Marubashi S; Dono K; Nagano H; Sugita Y; Asaoka T; Hama N; Miyamoto A; Takeda Y; Umeshita K; Monden M
    Transpl Int; 2007 Jul; 20(7):576-82. PubMed ID: 17425725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.
    Wong IH; Lau WY; Leung T; Yeo W; Johnson PJ
    Clin Cancer Res; 1999 Dec; 5(12):4021-7. PubMed ID: 10632334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of alpha-fetoprotein mRNA in peripheral blood in liver resection for hepatocellular carcinoma.
    Marubashi S; Nagano H; Wada H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
    Ann Surg Oncol; 2011 Aug; 18(8):2200-9. PubMed ID: 21301972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
    Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
    Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver.
    Funaki NO; Tanaka J; Seto SI; Kasamatsu T; Kaido T; Imamura M
    Hepatology; 1997 Mar; 25(3):564-8. PubMed ID: 9049199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein mRNA detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation.
    Marubashi S; Dono K; Sugita Y; Asaoka T; Hama N; Gotoh K; Miyamoto A; Takeda Y; Nagano H; Umeshita K; Monden M
    Transplant Proc; 2006 Dec; 38(10):3640-2. PubMed ID: 17175354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood].
    Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma.
    Cillo U; Navaglia F; Vitale A; Molari A; Basso D; Bassanello M; Brolese A; Zanus G; Montin U; D'Amico F; Ciarleglio FA; Carraro A; Bridda A; Burra P; Carraro P; Plebani M; D'Amico DF
    Clin Chim Acta; 2004 Sep; 347(1-2):129-38. PubMed ID: 15313150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitation of alpha-fetoprotein messenger RNA in peripheral blood of nude mice and its relationship with tumor recurrence and metastasis after curative resection of hepatocellular carcinoma].
    Wu X; Lin Z; Fan J; Lu J; Wang L; Tang Z
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):189-91. PubMed ID: 12113675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of tumor cells spreading in blood to relapse and distant metastasis of hepatocellular carcinoma after surgery].
    LIU Y; ZHANG GT; WU MC
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(20):1583-5. PubMed ID: 19094658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
    Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
    Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.
    Zhou YM; Yang JM; Li B; Yin ZF; Xu F; Wang B; Xu W; Kan T
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):33-7. PubMed ID: 20133226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
    Park UJ; Kim YH; Kang KJ; Lim TJ
    Korean J Hepatol; 2008 Sep; 14(3):371-80. PubMed ID: 18815460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.